USPTO Deadlines
Application History
17 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 18, 2021 | FINT | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Mar 30, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Mar 30, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Feb 13, 2021 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| Jan 27, 2021 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Jan 27, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 30, 2020 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| Mar 30, 2020 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 5, 2019 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Sep 14, 2019 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Sep 14, 2019 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Sep 6, 2019 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Sep 5, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Sep 3, 2019 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Aug 30, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Aug 30, 2019 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Aug 22, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Pharmaceutical products and substances; dermatological products; pharmaceutical products for the treatment of acne, keratosis, seborrhea, psoriasis, signs and symptoms of photo-aging; products for the repair and healing of nerve endings; medical products for skin restoration and growth, namely, products injected in or under the skin, in or under mucous membranes, in or under adipose tissues for use as alternatives to a plastic surgery treatment and/or for filling, remodeling, increasing the volume of any part of the body and for skin regeneration; cartilage reconstruction product; disc hernia treatment product; vaccine vector product
First Use Anywhere:
0
First Use in Commerce:
0
Class 010
Surgical, medical and veterinary apparatus and instruments; syringes for injection of dermatological products; suture material; implant of any kind and for any use and in particular general surgery implants, visceral and parietal surgery implants, implants for reconstructive and aesthetic surgery, cardiovascular implants, dental implants, orthopedic implants; biocompatible materials for medical use including visco-supplementation substances, designed to fill wrinkles and increase volume
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Scientific and medical research; design and development of pharmaceutical and therapeutic products; consultancy with respect to the development of implants and prostheses; medical and scientific research in the field of pharmaceutical products
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consist of the stylized wording "BIOXIS PHARMACEUTICALS".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
010
042